Shalala, Gaetz Seek to Reschedule Cannabis and Develop National Research Agenda

September 20, 2019 by Sean Trambley

Reps. Donna Shalala, D-Fla., and Rep. Matt Gaetz, R-Fla., introduced the Expanding Cannabis Research and Information Act, bipartisan legislation that would facilitate research into the potential medical benefits and public health impacts of marijuana. 

The bill would develop a national cannabis research agenda, direct the U.S. Department of Health and Human Services to collect data on the health impacts of cannabis, establish a National Institutes of Health “Centers of Excellence” research designation, and reclassify cannabis as a Schedule III controlled substance.

Currently, 11 states and the District of Columbia have legalized adult cannabis use, while 33 states have legalized medical cannabis use. However, the Drug Enforcement Administration continues to classify cannabis as a Schedule I controlled substance with no medical benefit. 

The Expand Cannabis Research and Information Act would allow for a dramatic expansion in research around the health benefits and public safety impacts of cannabis use.

“For years now, states across the country have been liberalizing their cannabis laws without making corresponding investments in developing a better scientific understanding of the short and long-term benefits and effects of cannabis on human health,” Rep. Shalala said. “By rescheduling cannabis and directing our national research infrastructure to study and collect data on how it impacts health outcomes, we are not only bringing federal cannabis policy into the 21st century, but we’re also guaranteeing that we do so safely.”

“I am proud to work with Congresswoman Shalala on the Expanding Cannabis Research and Information Act,” Gaetz said. “This bipartisan and bicameral legislation will improve, expedite, and streamline cannabis research: by rescheduling cannabis to Schedule III, this bill will lessen the conflict between states and the federal government, and by designating “Centers of Excellence in Cannabis Research,” it will help unlock cures for America’s most vulnerable populations.”

Health

In Hamburg, ‘Gesundheit’ Means More Than a Wish for Good Health Health
In Hamburg, ‘Gesundheit’ Means More Than a Wish for Good Health

HAMBURG, Germany — Researchers around the world hail Germany for its robust health care system: universal coverage, plentiful primary care, low drug prices and minimal out-of-pocket costs for residents. Unlike in the U.S., the prospect of a large medical bill doesn’t stand in the way of... Read More

The Uncertainty of Government Run Healthcare Health
The Uncertainty of Government Run Healthcare
October 22, 2019
by Dan McCue

WASHINGTON - Accustomed as they are to believing government can do a great deal of good for a great many, serious Democrats have grown increasingly concerned over the potential long-term ramifications of Medicare for all proposals. While it's easy -- and perhaps hopeful -- to view... Read More

Bill Seeks to Provide Vision Coverage in Medicare, Lowering Costs for Seniors Medicare
Bill Seeks to Provide Vision Coverage in Medicare, Lowering Costs for Seniors
October 22, 2019
by Dan McCue

WASHINGTON - A quartet of House Democrats want to see Medicare Part B coverage expanded to include routine vision benefits. Right now, Medicare only covers surgery and screenings for people who are at a high risk of getting cataracts and glaucoma, but it but does not... Read More

Rose Hosts District Roundtable on Prescription Drug Prices Prescription Drugs
Rose Hosts District Roundtable on Prescription Drug Prices
October 22, 2019
by Dan McCue

WASHINGTON - Rep. Max Rose hosted a roundtable for seniors in Brooklyn, N.Y. on Saturday to bring them up to speed on his proposal to lower prescription drug prices. Rose met with members of AARP Bay Ridge Chapter 3630 to talk about his support of the... Read More

Spanberger Fighting to Strengthen Federal Investment in Cancer and Rare Disease Research Health
Spanberger Fighting to Strengthen Federal Investment in Cancer and Rare Disease Research
October 22, 2019
by Dan McCue

WASHINGTON - Rep. Abigail Spanberger, D-Va., wants $10 billion allocated to the National Institutes of Health over the next 10 years as a catalyst for medical cures and scientific breakthroughs. The Biomedical Innovation Expansion Act introduced last week by Spanberger and Reps. Mikie Sherrill, D-N.J., and... Read More

Governors Hold Summit on Regional Approach to Cannabis and Vaping Legislation State News
Governors Hold Summit on Regional Approach to Cannabis and Vaping Legislation
October 18, 2019
by Dan McCue

The governors of five northeastern states came together for a summit on Thursday to discuss the outlines of a joint regional approach to cannabis and vaping policies. "This issue is complicated, controversial and consequential. It is probably one of the most challenging I've had to address... Read More

Straight From The Well
scroll top